Fludeoxyglucose F 18-PET/CT Imaging in Assessing Response to Chemotherapy in Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Hodgkin Lymphoma
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00678327 |
Recruitment Status :
Completed
First Posted : May 15, 2008
Last Update Posted : May 8, 2024
|
Sponsor:
University College, London
Collaborators:
Cancer Research UK
Cancer Research UK & UCL Cancer Trials Centre
Information provided by (Responsible Party):
University College, London
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Completed |
---|---|
Actual Primary Completion Date : | January 31, 2016 |
Actual Study Completion Date : | May 1, 2024 |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):